EMA To Probe HBV Reactivation With Direct-Acting Antivirals
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has begun a review of the direct-acting antivirals for hepatitis C in light of a number of recent cases showing that hepatitis B virus has been reactivated in some HCV patients treated with the newer products.